OpenOnward

Regenerative medicine gets a boost from new FDA guidance for drug development

FDA announces comprehensive regenerative medicine policy framework FDA announces comprehensive regenerative medicine policy framework to spur innovation, efficient access to potentially transformative products, while ensuring safety and efficacy.

Historic event in medicine today: First patient dosed with genome-editing therapy.

Sangamo Announces Treatment of First Patient in Landmark Phase 1/2 Clinical Trial Evaluating In Vivo Genome Editing for MPS II :: Sangamo Therapeutics, Inc. (SGMO) Sangamo Announces Treatment of First Patient in Landmark Phase 1/2 Clinical Trial Evaluating In Vivo Genome Editing for MPS II Download as PDF November 15, 2017 RICHMOND, Calif., Nov. 15, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO) today announced treatment of the first patient in...

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma — NEJM Original Article from The New England Journal of Medicine — Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

Circadian rhythm wins Nobel Prize in Medicine

Nobel Prize in Medicine Awarded for Discoveries About Circadian Rhythm Jeffrey C. Hall, Michael Rosbash and Michael W. Young were recognized for research into the cellular mechanisms controlling the body’s 24-hour cycle.